Strides Pharma to set up 800-mn capacity vaccine suite in Bengaluru

In talks with global players seeking manufacturing opportunity for potential Covid-19 vaccine

Eyeing the vaccine opportunity created by the Covid-19 pandemic, Strides Pharma Science is in the process of setting up a vaccine suite in Bengaluru, said a top company official. The vaccine lines are a part of the $40 million investment that the company had committed for its associate Stelis Biopharma.

“Existing vaccine capacities globally are not sufficient to cater to the entire global population and there is going to be high demand,” said R Ananthanarayanan, managing director & chief executive officer of the Bengaluru-headquartered pharma company.

Strides is in discussions with all the global players who are in advanced stages